Applied Biosystems and Agilent Technologies Reach Settlement Agreement Regarding Real-Time PCR Thermal Cyclers
Complete the form below to unlock access to ALL audio articles.
Applied Biosystems, an Applera Corporation business, and Agilent Technologies have entered into a settlement agreement resolving patent infringement lawsuits originally filed by Applera against Stratagene (acquired by Agilent in 2007), alleging infringement of Applera’s Real-Time thermal cycler instrument patents.
The lawsuits resulted in injunctions in Germany and the Netherlands and were pending in the U.S. and France.
In connection with the settlement, Agilent has entered into an agreement with Applera to license certain Applera technology relating to Agilent’s Real-Time thermal cycler instrument business in research-related fields and excluding the field of human in vitro diagnostics.
The two companies also announced that Agilent has entered into another agreement with Applera to license certain Applera technology relating to Agilent’s PCR and Real-Time enzymes and kits.
Financial terms of the settlement and related license agreements were not disclosed.
These agreements fully resolve all pending disputes between Applera and Stratagene.
